The Global Fund Programme in Myanmar

1. Goal:

To eliminate the indigenous transmission of Plasmodium falciparum (Pf) malaria by 2026 and put Myanmar on the path to eliminate all human malaria by 2030.

2. Target Group/Beneficiaries:

Malaria endemic populations:

• All villages, including those of ethnic minority groups;
• Communities close to forested areas;
• Internally displaced persons (IDP);
• Camps associated with large-scale construction projects (dams, bridges, mines, etc.);
• Settlements associated with plantations (rubber, oil palm, food);
• Seasonal agricultural laborers;
• Forest workers in the formal sector (police, border guards, forest/wildlife protection services) and informal sector (hunters, small-scale gem/gold miners, people gathering forest products such as precious timber, construction timber, rattan/bamboo);
• Transient or mobile camps associated with commercial projects (road/pipeline construction, large-scale logging, deep seaport projects);
• Formal and informal cross-border migrant workers.

3. Objectives:

• Achieve zero indigenous Pf malaria cases by 2026.
• Reduce all species malaria morbidity by 67% relative to the 2021 baseline figure and reduce mortality associated with indigenous malaria to zero by 2026.
• Prevent the re-establishment of indigenous transmission of Pf/all species malaria in townships where transmission has been interrupted.
• Prevent the emergence/introduction and spread of artemisinin-based combination therapy (ACT) resistant Pf malaria in Myanmar.

4. Planned Activities:

• Case management through volunteers, public health facilities and private sector;
• Intensification Plan and Acceleration Strategies by Stratum
• Accelerator Strategy to accelerate Pf elimination including Mass Drug Administration, Targeted Drug Administration, and household active fever screening.;
• Activities specific for malaria elimination (including active case investigation, foci investigation and response);
• Vector control activities (including LLIN mass campaign, continuous LLIN distribution, entomological monitoring and Indoor Residual Spray (IRS));
• Vector control and case management activities targeting migrant, mobile, ethnic and vulnerable populations;
• Equitable access to malaria testing and treatment, particularly among the hardest-to-reach communities;
• Cross-border collaboration meetings;
• RSSH activities (case-based surveillance and reporting through an electronic reporting system as well as routine monitoring activities);
• Surveys such as community-based and operational research;
• Strengthening Integrated Drug Efficacy Surveillance (iDES) by collaborating with Department of Food and Drug Administration; 
• Strengthening regional surveillance across GMS countries through a regional data-sharing platform.